{"DataElement":{"publicId":"2939337","version":"1","preferredName":"Cytogenetic Analysis And/Or Molecular Analysis Laboratory Procedure BCR-ABL Oncoprotein And Philadelphia Chromosome Positive Finding Type","preferredDefinition":"A description of the type of cytogenetic and or molecular abnormality that showed a positive finding.","longName":"3124165v1.0:2939335v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3124165","version":"1","preferredName":"Cytogenetic Analysis And/Or Molecular Analysis Laboratory Procedure BCR-ABL Oncoprotein And/Or Philadelphia Chromosome Positive Finding","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._Used to indicate that either or both of two items or options may be valid._A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._An onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190). Aberrant expression of BCR-ABL in bone marrow cells results in a variety of leukemias._Used to indicate that either or both of two items or options may be valid._A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML)._An observation confirming something, such as the presence of a disease, condition, or microorganism.","longName":"3135382v1.0:3135383v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3135382","version":"1","preferredName":"Cytogenetic Analysis And/Or Molecular Analysis Laboratory Procedure","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:Used to indicate that either or both of two items or options:Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C18280:C48928:C19770:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC2469C-9E71-26E7-E040-BB89AD43048A","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3135383","version":"1","preferredName":"BCR-ABL Oncoprotein And/Or Philadelphia Chromosome Positive Finding","preferredDefinition":"An onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190).:Used to indicate that either or both of two items or options:An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it.  Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia.:An observation confirming something, such as the presence of a disease, condition, or microorganism.","longName":"C16325:C48928:C28452:C38758","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Protein","conceptCode":"C16325","definition":"A fusion protein encoded by the BCR/ABL1 fusion gene. This protein is comprised of the N-terminus of the breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase ABL1 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC2469C-9E84-26E7-E040-BB89AD43048A","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BFE0E15-2982-292F-E040-BB89AD4373B8","latestVersionIndicator":"Yes","beginDate":"2010-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-07-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2939335","version":"1","preferredName":"Cytogenetic Analysis And Molecular Analysis Positive Finding Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level._An observation confirming something, such as the presence of a disease, condition, or microorganism._Type; a subdivision of a particular kind of thing.","longName":"2939335v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BCR / ABL rearrangement","valueDescription":"BCR-ABL Oncoprotein Gene Rearrangement","ValueMeaning":{"publicId":"3135400","version":"1","preferredName":"BCR-ABL Oncoprotein Gene Rearrangement","longName":"3135400","preferredDefinition":"An onco-protein generated from the fusion of Bcr and Abl genes by translocation process between chromosome 9 and 22 (Philadelphia chromosome), in CML (P210) and some ALL (P190).: Covalent DNA changes in cells during normal differentiation resulting in new sequences, expression, or gene products; this is a mechanism of binding site diversification for antibodies, certain receptors, and possibly other proteins. The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development. This includes the ordered rearrangement of variable gene regions; especially, the rearrangement of antibody genes during the differentiation of B-lymphocytes and the rearrangement of T-cell antigen receptor genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BCR/ABL1 Fusion Protein","conceptCode":"C16325","definition":"A fusion protein encoded by the BCR/ABL1 fusion gene. This protein is comprised of the N-terminus of the breakpoint cluster region protein fused to almost the entire tyrosine-protein kinase ABL1 protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Rearrangement Process","conceptCode":"C16611","definition":"Any DNA sequence rearrangement that results in the creation of a novel protein-coding capacity. Within certain genes, gene rearrangement is a normal part of development, facilitating the affinity maturation of B and T lymphocytes as well as class switching of immunoglobulins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC33B02-7F55-9ED8-E040-BB89AD431347","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC33B02-7F6E-9ED8-E040-BB89AD431347","beginDate":"2009-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"},{"value":"Ph-chromosome, t(9;22)(q34;q11) and variants","valueDescription":"Philadelphia Chromosome And/Or Variation","ValueMeaning":{"publicId":"3135407","version":"1","preferredName":"Philadelphia Chromosome And/Or Variation","longName":"3135407","preferredDefinition":"An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it.  Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia.: Used to indicate that either or both of two items or options: An alteration or difference from a norm or standard.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Variation","conceptCode":"C25713","definition":"An alteration or difference from a norm or standard.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8FC3CB7A-F26A-2AEB-E040-BB89AD4339B1","latestVersionIndicator":"Yes","beginDate":"2010-09-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8FC3CB7A-F283-2AEB-E040-BB89AD4339B1","beginDate":"2009-09-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2010-09-08","modifiedBy":"ONEDATA","dateModified":"2010-09-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3303111","version":"1","preferredName":"Cytogenetic Analysis And Molecular Analysis Positive Finding Type","preferredDefinition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.:An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.:Techniques for studying or analyzing the genetic composition and mechanisms of living organisms at the molecular level. May refer to the understanding and manipulation of genes (DNA).:An observation confirming something, such as the presence of a disease, condition, or microorganism.:Type; a subdivision of a particular kind of thing.","longName":"3303111v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Analysis","conceptCode":"C18280","definition":"Techniques for analysis of chromosomal and subchromosomal properties and structures, such as those to diagnose, classify, screen for, or manage genetic diseases and abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Molecular Analysis","conceptCode":"C19770","definition":"A laboratory procedure that involves the study of tissues, cells, and fluids using DNA/RNA analysis techniques for the identification of characteristics and abnormalities at the molecular level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B165DCF6-0412-5175-E040-BB89AD432D3B","latestVersionIndicator":"Yes","beginDate":"2011-11-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-11-10","modifiedBy":"ONEDATA","dateModified":"2011-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"732CDE95-7D91-9757-E040-BB89AD4318E5","latestVersionIndicator":"Yes","beginDate":"2009-09-09","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-09","modifiedBy":"KUMMEROA","dateModified":"2012-03-26","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964929","version":"1","longName":"2012r1: CML Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279271","version":"1","longName":"Disease Status","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify which type of cytogen","type":"Preferred Question Text","description":"Specify which type of cytogenetic and or molecular abnormalities showed a positive result:","url":null,"context":"NHLBI"},{"name":"Specify which abnormalities showed a positive result:","type":"Alternate Question Text","description":"Specify which abnormalities showed a positive result:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2939337","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.Value(ANY=>CD) WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"Perform Cytogenetic Analysis And/Or Molecular Analysis Laboratory Procedure BCR-ABL Oncoprotein And/Or Philadelphia Chromosome Positive\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"732CDE95-7DDC-9757-E040-BB89AD4318E5","latestVersionIndicator":"Yes","beginDate":"2009-09-09","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-09","modifiedBy":"KUMMEROA","dateModified":"2021-08-17","changeDescription":". 2021-8-17 ak System generated def displayed as alt def. 12/05/12mn-removed alt name for 2012 cml_base_bcr_abl_pos_yn - (not to be under type cde).","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}